Home | Courses | Residential Care |
Shingles Explained
Course Description
Shingles is an infection caused by the varicella-zoster virus (VZV). It affects millions globally, with an estimated 1 in 3 people experiencing it during their lifetime. This course examines how VZV is reactivated and transmitted, along with signs and symptoms, potential complications, and effective prevention and management strategies to minimise the impact of shingles in the older person.
Learning Outcomes
By the end of this course, learners should be able to:
* Define shingles
* Recognise signs and symptoms of shingles
* Explain how the varicella-zoster virus (VZV) is transmitted
* Identify who is at risk of shingles
* Identify complications of shingles
* Describe treatment options for shingles
* Describe management and prevention strategies for shingles
Course Code:
AOC17263-B-R-UKCPD Points:
0.5Course Availability:
Available NowTopics:
Library:
Residential CareCollection:
Care & ClinicalSubject Matter Expert:
Dr Robert Johnson
Robert Johnson trained in Medicine at St. Bartholomew’s Hospital, London, qualifying in 1967. Specialist training in anaesthesia and pain management was undertaken in Bristol. This included a one year secondment to the University of Virginia Pain Studies Clinic in Charlottesville, USA where his interest in herpes zoster (HZ) started. In 1975 he was appointed as a Consultant in Anaesthesia with Pain Management at the Bristol Royal Infirmary, UK.
His clinical and research interest in HZ continued and he developed a specialist herpes zoster clinic for patients with zoster associated pain (ZAP).
With his wife, a specialist research nurse, he undertook many studies mostly involved with prevention and management of postherpetic neuralgia (PHN). His research led to the award of the degree of Doctor of Medicine in the University of Bristol.
He has 73 publications on HZ in peer reviewed specialist journals and 8 chapters in textbooks. His current research interests include prevention of PHN by administration of low-dose amitriptyline, commenced soon after HZ has been diagnosed. He is also involved in the analysis of detailed notes and illustrations for 515 HZ sufferers studied by Henry Head, a neurologist, between 1890 and 1907. He is currently the Hon. Senior Research Fellow, Translational Medicine, Faculty of Health Sciences, University of Bristol, UK.
